Citizens JMP lowered the firm’s price target on Bowhead Specialty (BOW) to $40 from $43 and keeps an Outperform rating on the shares. The firm expects Q3 results for the insurance sector to be highlighted by lighter-than-typical catastrophe losses, modest mark to market book value tailwinds, and potential for continued issues around casualty loss reserves, but thinks focus will be zeroed in on the pricing environment, the analyst tells investors in a research note.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty price target lowered to $33 from $39 at JPMorgan
- Bowhead Specialty price target lowered to $31 from $34 at Morgan Stanley
- Bowhead Specialty price target lowered to $38 from $42 at Keefe Bruyette
- Bowhead Specialty Expands Board with New Director
- Bowhead Specialty price target lowered to $33 from $38 at Piper Sandler